Alpha-carbolines for the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9428500
APP PUB NO 20150105554A1
SERIAL NO

14399925

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I) as herein described and pharmaceutical compositions thereof, as well as to key intermediates towards their synthesis. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE DE GENEVE24 RUE DU GÉNÉRAL-DUFOUR GENEVA 4 1211
UNIVERSITE CLAUDE BERNARD - LYON 169100 VILLEURBANNE
UNIVERSITA DEGLI STUDI DI MILANO - BICOCCA20126 MILANO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahmed, Shaheen Genève, CH 5 48
Benoit, Joseph Villeurbanne, FR 1 0
Bisson, William Genève, CH 3 1
Gambacorti-Passerini, Carlo Monza, IT 5 28
Goekjian, Peter Villeurbanne, FR 6 1
Gueyrard, David Villeurbanne, FR 4 47
Mologni, Luca Vedano Al Lambro, IT 4 36
Orsato, Alexandre Villeurbanne, FR 1 0
Scapozza, Leonardo Genève, CH 11 179
Tardy, Sébastien Villeurbanne, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 29, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00